0001950047-24-007232.txt : 20240918 0001950047-24-007232.hdr.sgml : 20240918 20240918164023 ACCESSION NUMBER: 0001950047-24-007232 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240918 DATE AS OF CHANGE: 20240918 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AC Immune SA CENTRAL INDEX KEY: 0001651625 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37891 FILM NUMBER: 241308035 BUSINESS ADDRESS: STREET 1: EPFL INNOVATION PARK, BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 BUSINESS PHONE: 41 21 345 91 21 MAIL ADDRESS: STREET 1: EPFL INNOVATION PARK, BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Pfeifer Andrea CENTRAL INDEX KEY: 0001697107 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AC IMMUNE SA STREET 2: EPFL INNOVATION PARK BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 144 1 primary_doc.xml 144 0001697107 XXXXXXXX LIVE 0001651625 AC IMMUNE SA 001-37891 EPFL Innovation Park, Building B 1015 Lausanne V8 00000 41213459121 ANDREA M. A PFEIFER Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

20000 69200.00 99197829 09/18/2024 NASDAQ Common 06/01/2012 Previously Exercised Stock Options Issuer N 20000 06/01/2012 Cash Y The securities to be sold were acquired upon the vesting of previously exercised stock options on 06/01/2012 through 05/11/2016 09/18/2024 06/10/2024 /s/ Andrea M.A. Pfeifer